SIOX News and Press, Sio Gene Therapies Inc. From 10/15/21

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

These 3 Penny Stocks Could Be Worth Watching in October Finding the best penny stocks to buy in 2021 does not come without its challenges. Because of the overwhelming number of factors impacting the stock market right now, it is difficult to find potentially valuable penny stocks wi...

NEW YORK, and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today announced that it will present new clinical...

Xenon Pharmaceuticals XENE +90% on positive XEN1101 data in mid-stage focal epilepsy study Elmira Savings Bank ESBK +66% Community Bank System to buy Elmira Savings Bank in $82.8M all cash deal OpGen OPGN +30% after announcing preliminary Q3 revenue ahead of expe...

NEW YORK and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today announced that it will present new clinical ...

-  Study has now enrolled a total of nine patients across low-dose and high-dose cohorts -  On track to report 12-month topline safety, biomarker, and efficacy data from Type II low-dose AXO-AAV-GM1 cohort in October 2021 NEW YORK, and DURHAM, N.C., Sept. 09, 2021 (G...

–  Completed targeted enrollment of Type II patients in ongoing dose-escalation study of AXO-AAV-GM1 in GM1 gangliosidosis –  On track to report 12-month topline safety, biomarker, and clinical outcomes data from low-dose cohort of AXO-AAV-GM1 in la...

Two new sample breakout stocks for Week 26 with better than 10% short-term upside potential. This past week, the peak gains were in PDSB +18.6% and FSTX +6.7% with Market and S&P 500 Momentum Gauges the most negative since February. 2021 MDA minimal returns are -2.8%, maximal ...

Fuwei Films (FFHL) +56% on Q1 results.Osmotica Pharmaceuticals (OSMT) +44% on deal to sell business and manufacturing facility.Pieris Pharmaceuticals (PIRS) +21% on development plans for PRS-220 in lung disease.Property Solutions Acquisition (PSAC) +16% on b...

Are These Biotech Penny Stocks Worth It? Finding the best biotech penny stocks to buy can be a challenge. As with any investment, there is quite a lot of work that should go into it. While biotech stocks do trade similarly to others, there are a few nuances that investors should conside...